NOAEL Studies
Cosmetic Ingredient
2-Amino-3-Hydroxypyridine NOAEL Studies
INCI: 2-AMINO-3-HYDROXYPYRIDINE
CAS: 16867-03-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 60 | mg/kg bw/day | rat | oral | 91 day | Subchronic | SCCP; Hruby, R. (2005) A 132: 90-day oral toxicity study with rats. ARC Seibersdorfresearch GmbH, Seibersdorf, Austria, internal study code: HE 92 Archive code atHenkel KGaA, Düsseldorf, Report No. R 0500256 |
| COSMOS DB | NOAEL | 30 | mg/kg bw/day | rat | oral | 91 day | Subchronic | SCCP; Hruby, R. (2005) A 132: 90-day oral toxicity study with rats. ARC Seibersdorfresearch GmbH, Seibersdorf, Austria, internal study code: HE 92 Archive code atHenkel KGaA, Düsseldorf, Report No. R 0500256 |
SCCS Opinion 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.02 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.14 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =45 | mg/kg bw/day | - | - | - | NOAEL study | p.19 |
ECHA 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | NOAEL | =30 | mg/kg bw/day | Rat | oral | chronic; 91 days | chronic | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eada2e4b0a7c65d1c536a; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/20708/7/6/2?documentUUID=609ca98b-8aa6-46ba-af68-283e5f23fcbf; YEAR=2005; ORIGINAL_YEAR=2005; TOXICOLOGICAL_EFFECT=behaviour (functional findings)|urinalysis|water consumption and compound intake|body weight and weight gain|clinical biochemistry|food consumption and compound intake|gross pathology|haematology|histopathology: neoplastic|mortality|ophthalmological examination|organ weights and organ / body weight ratios; TOXICOLOGICAL_EFFECT_CATEGORY=body weight|cancer|clinical chemistry|food and/or water consumption|gross pathology|hematology|mortality/survival|neurobehavior|organ weight|urinalysis; STUDY_GROUP=ECHA IUCLID:15846346:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_716b947741141c1a81856c52d5a653f2 |
| ECHA | NOAEL | =45 | mg/kg bw/day | Rat | oral | - | developmental | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eabf4e4b0a7c65d1bca76; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/20708/7/9/3?documentUUID=609ca98b-8aa6-46ba-af68-283e5f23fcbf; YEAR=2005; ORIGINAL_YEAR=2005; TOXICOLOGICAL_EFFECT=fetus: reduction in number of live offspring|fetus: changes in sex ratio|fetus: fetal/pup body weight changes|fetus: changes in litter size and weights|fetus: changes in postnatal survival|fetus: external malformations|fetus: skeletal malformations|fetus: visceral malformations; TOXICOLOGICAL_EFFECT_CATEGORY=development; STUDY_GROUP=ECHA IUCLID:15821068:-:-fetal; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_3e41dca4d15ed8329ec576759ccb9c1a |
Regulatory source 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 45 | mg/kg bw/day | - | - | - | - | p.19 |
| Regulatory source | dermal absorption | =0.02 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.20 |
| Regulatory source | dermal absorption | =30 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.20 |
| Regulatory source | genotoxicity | 30 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.14 |
| Regulatory source | irritation | 30 | mg/kg bw/day | rat | - | 90-day | irritation | p.21 |
| Regulatory source | irritation | 45 | mg/kg bw/day | rat | - | 90-day | irritation | p.21 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | P8740PEW4B | UNII | - | - | - | chemical | - |